Washington Editor (BioWorld)
Although top-line results of a Phase III efficacy trial showed that Altus Pharmaceuticals Inc.'s cystic fibrosis drug Trizytek (ALTU-135) hit its primary endpoint of improvement in fat absorption, the benefit was smaller than expected and results differed across various geographies.

Reporter's Notebook: Miguel Contreras (The Narco News Bulletin)
This Narco News report is about two tragic shooting incidents involving two U.S. Customs Service ( Customs ) Inspectors who got shot and wounded on April 17, 1997 at the Calexico, CA International Port of Entry, and the killing of a U.S. Customs & Border Protection ( CBP ) Special Agent assigned to the CBP s Office of Internal Affairs, Miami, FL on August 5, 2008. This author intend to bring a ...

I-Flow Corporation Enforcing Patent and Trade Secret Rights Against Apex Medical's SOLACE(R) Pump (Centre Daily Times)
I-Flow Corporation (NASDAQ:IFLO) has commenced a lawsuit against Apex Medical Technologies, Inc. and its president, Mark McGlothlin, for infringing I-Flow's United States Patent No. 5,284,481 and misappropriating I-Flow's valuable trade secrets. The legal action states the Solace Pump was developed using I-Flow's secret information and infringes I-Flow's patent.